These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15743175

  • 1. Synthesis of NO-donor bisphosphonates and their in-vitro action on bone resorption.
    Lazzarato L, Rolando B, Lolli ML, Tron GC, Fruttero R, Gasco A, Deleide G, Guenther HL.
    J Med Chem; 2005 Mar 10; 48(5):1322-9. PubMed ID: 15743175
    [Abstract] [Full Text] [Related]

  • 2. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H, Murakami A, Aggarwal BB.
    Mol Cancer Res; 2006 Apr 10; 4(4):275-81. PubMed ID: 16603641
    [Abstract] [Full Text] [Related]

  • 3. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K.
    Adv Drug Deliv Rev; 2005 May 25; 57(7):959-71. PubMed ID: 15876398
    [Abstract] [Full Text] [Related]

  • 5. [The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption].
    Yamamoto Y, Noguchi T, Udagawa N.
    Clin Calcium; 2005 Jul 25; 15(7):11-6. PubMed ID: 15995290
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
    Voronov I, Heersche JN, Casper RF, Tenenbaum HC, Manolson MF.
    Biochem Pharmacol; 2005 Jul 15; 70(2):300-7. PubMed ID: 15919055
    [Abstract] [Full Text] [Related]

  • 7. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K.
    J Clin Invest; 2006 Feb 15; 116(2):528-35. PubMed ID: 16424941
    [Abstract] [Full Text] [Related]

  • 8. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N, Nomura T, Noma H, Yokoo K, Takagi R, Hashimoto S, Okamoto M, Sato M, Yu G, Guo C, Shibahala T.
    Clin Cancer Res; 2005 Apr 01; 11(7):2713-9. PubMed ID: 15814653
    [Abstract] [Full Text] [Related]

  • 9. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.
    Bone; 2006 May 01; 38(5):678-85. PubMed ID: 16309985
    [Abstract] [Full Text] [Related]

  • 10. Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors.
    Huh YJ, Kim JM, Kim H, Song H, So H, Lee SY, Kwon SB, Kim HJ, Kim HH, Lee SH, Choi Y, Chung SC, Jeong DW, Min BM.
    Cell Death Differ; 2006 Jul 01; 13(7):1138-46. PubMed ID: 16224490
    [Abstract] [Full Text] [Related]

  • 11. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
    Regmi A, Fuson T, Yang X, Kays J, Moxham C, Zartler E, Chandrashekhar S, Galvin RJ.
    Bone; 2005 Feb 01; 36(2):284-91. PubMed ID: 15780954
    [Abstract] [Full Text] [Related]

  • 12. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
    Tanaka S, Nakamura K, Takahasi N, Suda T.
    Immunol Rev; 2005 Dec 01; 208():30-49. PubMed ID: 16313339
    [Abstract] [Full Text] [Related]

  • 13. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
    J Bone Miner Res; 2006 Feb 01; 21(2):193-206. PubMed ID: 16418775
    [Abstract] [Full Text] [Related]

  • 14. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE, Wordsworth PB, Edwards JR, Ferguson DJ, Athanasou NA.
    Hum Pathol; 2006 Sep 01; 37(9):1176-85. PubMed ID: 16938523
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W.
    Bone; 2006 Aug 01; 39(2):325-35. PubMed ID: 16580896
    [Abstract] [Full Text] [Related]

  • 16. [BMP and osteoclastogenesis].
    Nakamura M, Udagawa N, Yamamoto Y, Nakamura H.
    Clin Calcium; 2006 May 01; 16(5):809-15. PubMed ID: 16679623
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.
    Int Immunopharmacol; 2007 Dec 05; 7(12):1507-16. PubMed ID: 17920527
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G, Anderson G, Jones A, De Ciechi P, Settle S, Mnich S, Thiede M, Abu-Amer Y, Portanova J, Monahan J.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):1044-53. PubMed ID: 16501068
    [Abstract] [Full Text] [Related]

  • 20. Regulation of RANKL-induced osteoclastic differentiation by vascular cells.
    Tintut Y, Abedin M, Cho J, Choe A, Lim J, Demer LL.
    J Mol Cell Cardiol; 2005 Aug 15; 39(2):389-93. PubMed ID: 15893766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.